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Research
A number of pregnancy cohort studies exam-
ining the risks of potential endocrine-disrupt-
ing chemicals on pregnancy and infant and
child health are currently underway in North
America and Europe. Given the current inter-
est in the reproductive and developmental
effects of endocrine-modulating chemicals and
ongoing discussion about the appropriate
methods for measuring infant endpoints, con-
sensus is needed on robust and validated
methods that can be applied across studies so
consistency of results can be evaluated or,
where statistical power is limited, data can be
pooled. Twenty investigators from Canada,
the United States, and Europe attended the
workshop “Assessing Endocrine-Related
Endpoints within the First Years of Life”
(30 April–1 May 2007, Ottawa, Ontario,
Canada) and discussed their experiences in
measuring endocrine-sensitive endpoints in
the ﬁrst years of life and made recommenda-
tions for future research.
The objectives of this workshop were as
follows: 
• To share data, experiences, and ideas for
identifying and measuring postnatal
endocrine-sensitive outcomes associated with
exposure to environmental chemicals in utero
and in early postnatal life, with a focus on
a) infant reproductive tract development,
b) markers of growth and development, and
c) serum hormone levels
• To develop recommendations, if possible, on
standardized methods for measuring indica-
tors that would allow comparisons across
studies or pooling of data among studies
• To briefly describe methods for measuring
neurodevelopmental disorders and sensory
dysfunction as well as prenatal and postnatal
nutrition, critical cofactors in any study of
endocrine-sensitive outcomes (see Supple-
mental Material online at http://www.
ehponline.org/members/2008/11226/
suppl.pdf). 
Workshop Discussion
The workshop began with invited presenta-
tions, followed by discussions of measure-
ment issues, attempts to reach a consensus on
recommended methods and identiﬁcation of
areas for future research. The topics and dis-
cussion were not intended to be an exhaustive
survey of methods, but rather were focused
on endocrine-sensitive measures where there
is enough information to suggest standardiza-
tion is possible and where uncertainty or
debate remain about how to best make the
measurement. The validity of the specific
developmental endpoints discussed as indica-
tors of a speciﬁc endocrine target in humans
may still require further investigation.
Reproductive Tract Developmental
Endpoints and Anthropometric
Measures
Logistical considerations in the conduct of the
clinical exam. The timing of the exam
depends on the research question, the meas-
ures to be taken, and the ability of the
researchers to get the parent and infant into
the clinic. In addition, researchers must be
aware of developmental hormone changes
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An international workshop titled “Assessing Endocrine-Related Endpoints within the First Years of
Life” was held 30 April–1 May 2007, in Ottawa, Ontario, Canada. Representatives from a number
of pregnancy cohort studies in North America and Europe presented options for measuring various
endocrine-sensitive endpoints in early life and discussed issues related to performing and using
those measures. The workshop focused on measuring reproductive tract developmental endpoints
[e.g., anogenital distance (AGD)], endocrine status, and infant anthropometry. To the extent possi-
ble, workshop participants strove to develop or recommend standardized measurements that would
allow comparisons and pooling of data across studies. The recommended outcomes include thigh
fat fold, breast size, vaginal cytology, AGD, location of the testis, testicular size, and growth of the
penis, with most of the discussion focusing on the genital exam. Although a number of outcome
measures recommended during the genital exam have been associated with exposure to endocrine-
disrupting chemicals, little is known about how predictive these effects are of later reproductive
health or other chronic health conditions. Key words: anogenital distance, anthropometry,
endocrine disruptors, genital exam, hormones, infants, measurement, neurodevelopment, reproduc-
tive tract development, sexual dimorphism. Environ Health Perspect 116:948–951 (2008).
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and other sources of endocrine disruptors in
the diet. Ideally, newborn clinical exams
should be done within the first 24 hr after
birth; however, this may result in data being
collected by hospital staff members who are
not fully trained, thereby increasing variability.
The recommended ages for genital measure-
ments are a) neonates during the first day
after birth in the maternity ward, except for
premature infants, where the exam should
take place on the expected date of delivery;
b) 2–4 months of age to coincide with mini-
puberty, which reﬂects the hormonal surge of
gonadotropins [predominantly luteinizing
hormone (LH) in boys and follicle-stimulating
hormone (FSH) in girls] that occurs in early
infancy (Quigley 2002); and c) 6 months of
age to coincide with the post-minipuberty
period for most infants. (Note that girls can
have elevated FSH levels up to 4 years of age.)
It is recommended that clinical exams of
infants take place while they are still breast-
feeding (before 4–6 months of age) and before
other foods are introduced, to minimize
confounding by diet. 
The age and developmental stage of the
infant are also factors to consider when taking
physical measurements during the clinical
exam. Newborn measures tend to be easier to
obtain, as the babies move less and are not
dehydrated, and the exam is generally accept-
able to the parents. Likewise, exams at 3 and
6 months and at 3 years of age tend not to be
problematic. On the other hand, infants
8–9 months and 18 months of age show the
most distress from being separated from their
parents and may have difficulty adjusting to
the new environment. 
Digital photos of facial and genital fea-
tures may be useful for pattern recognition, at
least for discussion purposes; however, photos
have not been useful for taking reliable quan-
titative measurements. 
Infant girls. Genital exams of infant girls
should include examination of the vulva and
perineum for color intensity and moisture
level, which tends to be red and glistening
moist without estrogen exposure, as opposed
to pink and dull if there has been increased
estrogen exposure. In addition, vaginal cytol-
ogy (taken with a cotton-tipped swab from the
introitus) may be useful to show continued
estrogen stimulation at birth and at 6 months
(e.g., from soy formulas) (Bernbaum et al.
2008). The participants did not recommend
measuring the clitoral index (product of the
longest sagittal and transverse clitoral dimen-
sion) for research purposes. Although this
index is used clinically to evaluate virilized
genitalia, these measures can be inconsistent
because of variation in the amount of “squeez-
ing” force exerted by the examiner. Any labial
fusion should be noted. 
Qualitative measures such as labial color
and rugation are not useful, as there are too
few differences in prevalence and features may
vary with minipuberty. Although there are a
few studies of ultrasound and magnetic reso-
nance imaging scans of the internal female
genitalia, these methods may not be sensitive
enough for subtle endpoint changes and
require signiﬁcant resources. Breast tissue size
and anogenital distance (AGD) may be useful
measurements.
Infant boys. In infant boys, the order of the
genital examination is important, as repeated
contact can result in some erection of the penis
and retraction of the testes. The participants
recommended that the exam begin with
recording the testis position, followed by meas-
ures of penile width (where squeezing is less of
a problem), penile length, and AGD (see
Figure 1 in Romano-Riquer et al. 2007). In
Denmark, calipers are used and the penis is not
stretched, whereas in the United States, the
penis is stretched and a disposable wooden
stick is marked to record length. It is unknown
which of these two approaches for measuring
penile dimensions best reflects an androgen
response. One disadvantage of using calipers is
that they must be sterilized. Measures of penile
dimensions at several time points are useful,
with measures at birth representing the
endocrine environment in utero and those at
3–6 months likely reflecting both exposures
in utero and minipuberty. 
Penis length is the accepted clinical meas-
ure of androgenization; however, penis width
may also provide additional independent
information. Maternal age is inversely related
to stretched penis length and width in models
adjusted for birth weight (Romano-Riquer
et al. 2007). This ﬁnding is interesting in that
older pregnant women tend to have lower
testosterone levels (Carlsen et al. 2003; Troisi
et al. 2003), and testosterone levels seem to be
inversely related to birth size (Carlsen et al.
2006). This may also indicate that, at least in
humans, the penis dimension measures may
be more responsive than AGD to the intra-
uterine hormone environment. 
There was some discussion about whether
the location of testis (Scorer 1964) should be
measured quantitatively as the distance
between the pubic bone and testes. Although
this measurement is important, participants
agreed that it was difﬁcult to measure consis-
tently. Some maintained that testis location
should be included in any genital exam, and
they noted that testicular placement is a con-
tinuum from normal (fully descended) to
ectopic. Moreover, once technicians have
been trained, this measure is highly repeat-
able. In addition, it is possible to describe the
position of the testis ﬁrst before manipulation
and then measure how far the testis can be
pulled from the pubic bone along its normal
route of descent (Boisen et al. 2004). At
3 months of age, differences in the hormone
profile have been observed between those
infants who have a high versus low scrotal
position (Suomi et al. 2006). The distance
measured from pubic bone to top or middle
of the testis is usually done after manipulating
the testis into the lowest possible position by
gentle traction. Whether or not the variation
observed between infants will be substantial
enough to overcome variability introduced by
examiners remains to be seen and will likely
be study dependent.
Several participants also noted that testis
size/volume measurements may not be reli-
able unless ultrasound measures are available
to give quantifiable volume. Extensive train-
ing is critical. There has been some success in
measuring testis volume using modified
Prader beads (ﬁner gradations), but some par-
ticipants felt that this measure was not useful,
especially compared with the penile length
and width measures. Without an ultrasound
exam, it is also impossible to determine if the
measurement is testis alone or includes other
tissue, such as the epididymis or a small
hydrocele. Given that ultrasound would add
substantial cost and team effort, measures of
testis size are not routinely recommended and
should only be done if the specific research
question requires it.
Although gradation of scrotal size (e.g.,
small, medium, large) can be difﬁcult to meas-
ure, this may be a sensitive indicator of andro-
gen effect that does vary considerably among
populations. Pictures can be helpful in improv-
ing consistency, but reproducibility and scale
are a concern. This measure is not routinely
recommended and should be used with cau-
tion to address speciﬁc research questions. 
Subjective quantification of suprapubic
fat and measurement of anoscrotal distance
were not recommended.
Anogenital distances. AGD is a measure
of fetal androgen action commonly used in
animal studies and recently in human studies
(Longnecker et al. 2007; Swan et al. 2005).
Calipers or a wooden tongue depressor that
can be marked are two options for measuring
genital distances. Other suggestions include
dental ﬂoss or sutures. All things considered,
the participants agreed that the recommended
instrument for measuring AGD is a caliper
for both boys and girls. 
All measures should be repeated at least
once. In boys, AGD is measured in various
ways, including from the middle of the anus
to the anterior base of the penis, from the anus
to the posterior base of the penis, and from
the anus to the posterior base of the scrotum.
The measurement to the anterior base of the
penis is easier to standardize and the most reli-
able. The distance can vary slightly depending
on the amount of pressure exerted. In girls,
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to the fourchette and from the anus to clitoris
(see Figure 1 in Callegari et al. 1987). 
Systematic differences between trained
observers in measures of AGD have been
observed; however, this variation is relatively
small compared with the true differences
between babies (Romano-Riquer et al. 2007).
To compare different measures of AGD, the
coefficient of variation may not be the best
parameter to use. Instead, researchers should
calculate the ratio of the true variation among
subjects in the numerator and the total varia-
tion among subjects including measurement
error in the denominator (inter-rater reliability). 
In rodents, a small AGD at birth remains
shorter in adulthood; however, it is unknown
whether the same holds true for humans. It is
assumed that the dynamics could change post-
natally, depending on either a new exposure or,
for males, a congenital testicular dysgenesis
with delayed effects during pubertal and adult
development. One approach would be to
examine AGD in cases of ambiguous genitalia
and measure changes based on hormonal status
postnatally. At this point, the timing of post-
natal changes is speculative, but AGD may be
stable for at least the ﬁrst month of life. If lon-
gitudinal data are available, the dynamics of
AGD may prove more sensitive for anti-
androgenic effects than a single measurement. 
Breast tissue. The amount of breast tissue
in boys and girls can be palpated, measured,
and compared with fat mass (Bernbaum et al.
2008; Schmidt et al. 2002); however, breast
tissue size can be difﬁcult to distinguish from
the surrounding fat, and an ultrasound may
be helpful. The diameter of breast buds, if
present, can be measured using disc-shaped
beads in 2-mm increments from 4 to 22 mm,
strung in an ordered set (Bernbaum et al.
2008). The number of nipples in humans is
not sexually dimorphic; therefore, this out-
come was considered to be of little impor-
tance in studies of endocrine disruption. In
rodents, however, this is a useful outcome. 
Body fat. From a research perspective, body
composition and fat are important outcomes,
but these are among the most challenging and
potentially upsetting examinations for both the
technicians and the babies. The skin fold caliper
spring tends to tighten the longer it is left on,
causing pinching and resulting in variability of
the measure. The hardest skin fold measure to
take is the thigh (quadriceps); however, the
thigh is a measure with great sexual dimor-
phism. Because it is distressing for babies, thigh
fat measures should be done at the end of the
exam. Other possible measurements include
circumferences of the upper arm and leg.
A bioimpedance scale can measure body
composition well, but it is important to have
some estimate of hydration if the measures
are not taken after standardized fasting.
Air-displacement plethysmography is a new
technique for infant measurements that looks
promising (Ellis et al. 2007).
Anthropometry. In addition to the measures
already discussed, workshop participants rec-
ommended recording standard measures of
body size (Lohman et al. 1988). Measures of
birth length and head circumference noted on
medical charts are not sufﬁciently accurate for
research purposes. For birth length, the kidime-
ter, as used in Denmark, or an infantometer
(used in North America) can accurately meas-
ure length with both legs completely extended.
For weight, it is critical that the scales are rou-
tinely calibrated. 
To facilitate standardization of methods
for head and abdominal circumference, land-
marks where the measurements will be taken
must be identiﬁed. For abdominal circumfer-
ence, the umbilicus can be used as a landmark.
Participants felt that interpretation of waist
circumference in newborns was unclear; how-
ever, this is an important postnatal measure.
The recommended landmark for head circum-
ference is a perpendicular line over the eye-
brows and above the ears. Participants
recommended that a paper lasso be used [such
as those available through the U.K. Child
Growth Foundation (2008)], which allows the
technician to tighten the lasso at the largest
point and allows one hand to be free.
The recommended ages for anthropome-
try are at birth, 3 and 6 months, 1 year, and
then annually thereafter. International growth
curves for children between birth and 2 years
of age are available through the World Health
Organization (WHO 2008).
Research needs. For the male infant popu-
lation, observations of markers of anti-
androgen or estrogenic activity are of interest;
in girls, however, the impact of androgens
and estrogens is less clear. For female infants,
noninvasive measurements that can be
obtained reliably and biomarkers for andro-
gen and estrogen effects need to be developed. 
At this point, there are no gold standard
measures, with most measures having some
merit. Therefore, it would be useful to com-
pare instruments to determine which measures
have the strongest association with prenatal
exposures or other factors of interest. Research
to help separate the impact of in utero expo-
sures from the effects of the postnatal environ-
ment is needed. A related research question is
how the postnatal environment can add to or
modify the effects of the prenatal environment. 
With respect to AGD and related meas-
ures, a major research need is identifying the
best approach to normalize these by the size
and age of the baby. Suggestions include
adjusting for gender-speciﬁc weight percentile,
age, and length. 
In animal studies, AGD is an important
indicator of a developmental endocrine effect;
however, it is unknown whether the same is
true in humans. Other research needs or data
gaps include: a) identifying the most impor-
tant cofactors that should be measured (e.g.,
ethnicity, anthropometry); b) collecting nor-
mative data; and c) collecting longitudinal
data to examine whether relative AGD and
other measures change with age. 
Another unresolved issue is the utility of
measuring testis volume. Signiﬁcant growth in
the testis occurs between birth and 3 months
of age. However, growth rates can vary signiﬁ-
cantly between populations, and it is unknown
whether such differences will result in any
problems for the population with slower
growth rates. 
Research is needed on how to describe
scrotal characteristics and measure its size.
Pictures can be helpful in improving consis-
tency, especially if issues of scale and approval
of human subjects are adequately addressed.
An unstudied area is whether, in adulthood,
differences in sperm quality will be observed
between those men whose testes were in a high
versus low scrotal position and those whose
testes were or were not retractile in infancy. 
Additional research needs include better
methods for measuring skin fold thickness of
the thigh and additional data on inter-rater
reliability of the assessments.
Hormonal Measures
Although most hormonal measures of interest
can be examined easily in blood samples, these
samples are often a challenge to collect from
infants and children. In Scandinavian coun-
tries, collection of blood from infants (10 mL
at 3 months of age) has not been the ethical
challenge that it has been in North America.
Although a heel stick may be more tolerable
for parents and ethics committees, it may be
more painful for the infant than venipuncture
(Ogawa et al. 2005). Finger pricks may be
more acceptable, but less blood is obtained,
and they are more painful than heel sticks. 
Gonadal axis. The preferred age for
obtaining infant blood measurements is
2–4 months of age, which represents mini-
puberty when peak hormone levels can be
captured. For boys, this will give an indication
of Leydig cell function (FSH, testosterone,
and LH) and Sertoli cell function (inhibin B
and FSH). Hormonal measurements in girls
during minipuberty show activation of the
pituitary–gonadal axis, but with a large varia-
tion within the normal range (Chellakooty
et al. 2003). Minipuberty in girls can be cap-
tured by measuring FSH, estradiol, LH, and
inhibin A and B. Although obtaining addi-
tional blood at the time of routinely scheduled
blood draws (American Academy of Pediatrics
2007) is appealing, they generally fall outside
the period of greatest interest for capturing
hormone peaks. 
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A major problem is the poor detection
limit of currently available hormone assays for
estradiol and testosterone and their cross-
reactivity with other hormones in the immuno-
assays, which is of concern especially in cord
blood samples. Methods using gas chromatog-
raphy/mass spectrometry are sensitive at low
levels for steroid hormones. 
Thyroid axis. To study maternal thyroid
hormone levels and their effects on offspring
cognitive development, maternal blood should
be collected in the ﬁrst trimester and analyzed
for thyroid-stimulating hormone (TSH) and
free thyroxine (T4). As part of newborn
screening in most developed countries and
U.S. states, TSH (and T4 in some places) is
measured from blood collected by heel pricks
spotted onto filter paper. Workshop partici-
pants recommended that thyroid hormone
levels (TSH, total T4, free T4, and total tri-
iodothyronine) be measured at 3 months of
age. If infant blood cannot be collected, col-
lecting maternal blood during the third
trimester and cord blood should be consid-
ered, as this would allow the separation of
maternal and fetal hormone levels (Dussault
JH, Morissette J, unpublished data). Infant
and maternal urine can also be analyzed for
gonadotropins and iodine (which is a con-
stituent of thyroid hormone). 
The participants recommended caution
when interpreting hormone levels at birth, as
both the baby and mother are under trauma
and stress to various extents due to delivery
(unless there is a very large effect of the pre-
natal exposure). 
Because there are a number of parallel
mechanisms related to steroidogenesis, the
adrenal hormones should not be ignored.
Adrenal hormones can be measured in amni-
otic ﬂuid, blood, and saliva, but they are difﬁ-
cult to measure in urine, and regardless of
matrix, diurnal variation needs consideration.
In saliva, only free hormones can be meas-
ured, and there is still ongoing debate as to
whether saliva measures are well correlated
with serum levels. Adrenocorticotrophic hor-
mone is very pulsatile and can be measured in
blood but is unlikely to be found in saliva. 
Research needs. More data are needed on
the timing of early hormonal peaks in infants.
Because of the difficulty in obtaining infant
blood samples, other matrices such as saliva,
urine, placenta, and meconium need to be
explored for measuring hormones. Collecting
large volumes of saliva from infants using 
currently available methods can be difﬁcult and
cause abrasion with bleeding (Umbach D,
Phillips T, Davis H, Archer J, Ragan B,
Bernbaum J, et al., unpublished data). Filter
paper may be used for collection of smaller vol-
umes of saliva. Improved methods are needed
to assay hormones on ﬁlter paper from saliva or
heel stick (as part of newborn screening). 
Conclusions
Overall the participants agreed that to evaluate
the utility of various measures in predicting
speciﬁc health outcomes, common standard-
ized measures have to be employed across stud-
ies. For the clinical genital exam for boys, the
order of the measurements is important and
should begin with recording the testis position,
followed by measures of penile width, penile
length, and AGD. With respect to AGD and
related measures, a major research need is iden-
tifying the best approach to normalize them by
the size of the baby. The recommended ages
for anthropometry are at birth, 3 and 6
months, 1 year, and then annually thereafter.
The preferred age for obtaining infant
blood measurements is 2–4 months of age,
which represents minipuberty (Quigley 2002)
when peak hormone levels can be captured.
In addition to gonadal effects, other hor-
monal systems, such as the thyroid and
adrenal glands, may also be affected by expo-
sure to endocrine disruptors and should be
included in future studies. 
The fetus and young infant appear to be
susceptible to endocrine-disrupting effects of
environmental chemicals. As exposure during
critical developmental phases such as in utero
and in the early postnatal period may have an
adverse effect on reproductive health and
neurodevelopment, research in this area should
be increased. Such research should continue to
search for valid biomarkers of endocrine dys-
function and at the same time include the
existing measurements as described above, to
facilitate comparability between study groups.
Preferably, such studies should be planned
longitudinally to increase our knowledge on
whether early markers of hormonal distur-
bance may have a lasting effect into puberty
and adulthood.
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